Clinicians are reminded to include non-prescription supplement history when evaluating thrombotic events in younger adults ...

Does an elevated ultrasensitive D-dimer level in a patient whose pre-test probability puts him at low risk for pulmonary embolus (PE) indicate an increased risk for PE or deep venous thrombosis (DVT)?

The investigation included 2993 CTPAs in 2655 patients over an approximately 2.5-year period. The authors compared the diagnostic yield of the override group (563 CTPAs in patients with a Wells score ...

Tampa, FL (Oct. 26, 2021) --A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized ...

Feasibility of a prospective host cell reactivation assay (HCRA) in non-small cell lung cancer (NSCLC) patients. Background: Procoagulant changes in the haemostatic system and activation of ...

The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still spreading across many parts of the world, and clinicians are working on recognizing biomarkers ...

Investigational tests and treatments performed in terminal-stage cancer patients in two weeks before death: Supportive care study group in Turkish Oncology Association. This is an ASCO Meeting ...